Mammographic Density Decline, Tamoxifen Response, and Prognosis by Molecular Characteristics of Estrogen Receptor-Positive Breast Cancer
Abubakar M, Mullooly M, Nyante S, Pfeiffer RM, Aiello Bowles EJ, Cora R, Bodelon C, Butler E, Butcher D, Sternberg L, Troester MA, Weinmann S, Sherman M, Glass AG, de Gonzalez AB, Gierach GL. JNCI Cancer Spectr. 2022 May 02;6(3). PMID: 35583138 PMCID: PMC9070642
Laboratory-related outcomes from integrating an accessible delivery model for hereditary cancer risk assessment and genetic testing in populations with barriers to access
Amendola LM, Shuster E, Leo MC, Dorschner MO, Rolf BA, Shirts BH, Gilmore MJ, Okuyama S, Zepp JM, Kauffman TL, Mittendorf KF, Bellcross C, Jenkins CL, Joseph G, Riddle L, Syngal S, Ukaegbu C, Goddard KAB, Wilfond BS, Jarvik GP, CHARM Study. Genet Med. 2022 06;24(6):1196-1205. Epub 2022-03-16. PMID: 35305866
Identifying patients with Lynch syndrome using a universal tumor screening program in an integrated healthcare system
Crain PR, Zepp JM, Gille S, Jenkins L, Kauffman TL, Shuster E, Goddard KAB, Wilfond BS, Hunter JE. Hered Cancer Clin Pract. 2022 Apr 18;20(1):17. Epub 2022-04-18. PMID: 35436948 PMCID: PMC9014602
Motivations and concerns of patients considering participation in an implementation study of a hereditary cancer risk assessment program in diverse primary care settings
Duenas DM, Shipman KJ, Porter KM, Shuster E, Guerra C, Reyes A, Kauffman TL, Hunter JE, Goddard KAB, Wilfond BS, Kraft SA. Genet Med. 2022 03;24(3):610-621. Epub 2021-11-23. PMID: 34906471 PMCID: PMC8939763
The Kaiser Permanente Research Bank Cancer Cohort: a collaborative resource to improve cancer care and survivorship
Feigelson HS, Clarke CL, Van Den Eeden SK, Weinmann S, Burnett-Hartman AN, Rowell S, Scott SG, White LL, Ter-Minassian M, Honda SAA, Young DR, Kamineni A, Chinn T, Lituev A, Bauck A, McGlynn EA. BMC Cancer. 2022 Feb 25;22(1):209. Epub 2022-02-25. PMID: 35216576 PMCID: PMC8876075
Developing an algorithm across integrated healthcare systems to identify a history of cancer using electronic medical records
Gander JC, Maiyani M, White LL, Sterrett AT, Güney B, Pawloski PA, DeFor T, Olsen Y, Rybicki BA, Neslund-Dudas C, Sheth D, Krajenta R, Purushothaman D, Honda S, Yonehara C, Goddard KAB, Prado YK, Ahsan H, Kibriya MG, Aschebrook-Kilfoy B, Chan CH, Hague S, Clarke CL, Thompson B, Sawyer J, Gaudet MM, Feigelson HS. J Am Med Inform Assoc. 2022 06 14;29(7):1217-1224. PMID: 35348718 PMCID: PMC9196704
Establishing the Medical Actionability of Genomic Variants
Goddard KAB, Lee K, Buchanan AH, Powell BC, Hunter JE. Annu Rev Genomics Hum Genet. 2022 08 31;23:173-192. Epub 2022-04-01. PMID: 35363504 PMCID: PMC10184682
Mammary collagen is under reproductive control with implications for breast cancer
Guo Q, Sun D, Barrett AS, Jindal S, Pennock ND, Conklin MW, Xia Z, Mitchell E, Samatham R, Mirza N, Jacques S, Weinmann S, Borges VF, Hansen KC, Schedin PJ. Matrix Biol. 2022 01;105:104-126. Epub 2021-11-25. PMID: 34839002
ClinGen's Pediatric Actionability Working Group: Clinical actionability of secondary findings from genome-scale sequencing in children and adolescents
Hunter JE, Jenkins CL, Bulkley JE, Gilmore MJ, Lee K, Pak CM, Wallace KE, Buchanan AH, Foreman AKM, Freed AS, Goehringer S, Manickam K, Meeks NJL, Ramos EM, Shah N, Steiner RD, Subramanian SL, Trotter T, Webber EM, Williams MS, Goddard KAB, Powell BC, ClinGen. Genet Med. 2022 06;24(6):1328-1335. Epub 2022-03-25. PMID: 35341655 PMCID: PMC9156571
Should Health Systems Share Genetic Findings With At-Risk Relatives When the Proband Is Deceased? Interviews With Individuals Diagnosed With Lynch Syndrome
Hunter JE, Schneider JL, Firemark AJ, Davis JV, Gille S, Pawloski PA, Liang SY, Schlieder V, Rahm AK. J Patient Cent Res Rev. 2022 Fall;9(4):282-289. Epub 2022-10-18. PMID: 36340570 PMCID: PMC9584081
An accessible, relational, inclusive, and actionable (ARIA) model of genetic counseling compared with usual care: Results of a randomized controlled trial
Joseph G, Leo MC, Riddle L, Guerra C, Amendola LM, Gilmore MJ, Rolf BA, Dorschner MO, Zepp J, Biesecker BB, Caruncho M, Hunter JE, Keast E, Lewis HS, Duenas D, Kauffman T, Bulkley JE, Anderson KP, Jarvik GP, Goddard KAB, Wilfond BS, CHARM Study Team. Genet Med. 2022 Nov;24(11):2228-2239. Epub 2022-09-02. PMID: 36053287
Risk-reducing surgery in unaffected individuals receiving cancer genetic testing in an integrated health care system
Knerr S, Guo B, Mittendorf KF, Feigelson HS, Gilmore MJ, Jarvik GP, Kauffman TL, Keast E, Lynch FL, Muessig KR, Okuyama S, Veenstra DL, Zepp JM, Goddard KAB, Devine B. Cancer. 2022 08 15;128(16):3090-3098. Epub 2022-06-09. PMID: 35679147 PMCID: PMC9308746
Quantifying cancer risk from exposures to medical imaging in the Risk of Pediatric and Adolescent Cancer Associated with Medical Imaging (RIC) Study: research methods and cohort profile
Kwan ML, Miglioretti DL, Bowles EJA, Weinmann S, Greenlee RT, Stout NK, Rahm AK, Alber SA, Pequeno P, Moy LM, Stewart C, Fong C, Jenkins CL, Kohnhorst D, Luce C, Mor JM, Munneke JR, Prado Y, Buth G, Cheng SY, Deosaransingh KA, Francisco M, Lakoma M, Martinez YT, Theis MK, Marlow EC, Kushi LH, Duncan JR, Bolch WE, Pole JD, Smith-Bindman R. Cancer Causes Control. 2022 May;33(5):711-726. Epub 2022-02-02. PMID: 35107724 PMCID: PMC9596345
ORCA, a values-based decision aid for selecting additional findings from genomic sequencing in adults: Efficacy results from a randomized trial
Liles EG, Leo MC, Freed AS, Porter KM, Zepp JM, Kauffman TL, Keast E, McMullen CK, Gruß I, Biesecker BB, Muessig KR, Eubanks DJ, Amendola LM, Dorschner MO, Rolf BA, Jarvik GP, Goddard KAB, Wilfond BS. Genet Med. 2022 Aug;24(8):1664-1674. Epub 2022-05-06. PMID: 35522237 PMCID: PMC9586129
An Examination of the Ethical and Legal Limits in Implementing "Traceback Testing" for Deceased Patients
Martucci J, Prado Y, Rope AF, Weinmann S, White L, Zepp J, Henrikson NB, Feigelson HS, Hunter JE, Lee SS. J Law Med Ethics. 2022;50(4):818-832. PMID: 36883408 PMCID: PMC10009393
Literacy-adapted, electronic family history assessment for genetics referral in primary care: patient user insights from qualitative interviews
Mittendorf KF, Lewis HS, Duenas DM, Eubanks DJ, Gilmore MJ, Goddard KAB, Joseph G, Kauffman TL, Kraft SA, Lindberg NM, Reyes AA, Shuster E, Syngal S, Ukaegbu C, Zepp JM, Wilfond BS, Porter KM. Hered Cancer Clin Pract. 2022 Jun 10;20(1):22. Epub 2022-06-10. PMID: 35689290 PMCID: PMC9188215
Adaptation and early implementation of the PREdiction model for gene mutations (PREMM5™) for lynch syndrome risk assessment in a diverse population
Mittendorf KF, Ukaegbu C, Gilmore MJ, Lindberg NM, Kauffman TL, Eubanks DJ, Shuster E, Allen J, McMullen C, Feigelson HS, Anderson KP, Leo MC, Hunter JE, Sasaki SO, Zepp JM, Syngal S, Wilfond BS, Goddard KAB. Fam Cancer. 2022 04;21(2):167-180. Epub 2021-03-23. PMID: 33754278 PMCID: PMC8458476
Retrospective assessment of barriers and access to genetic services for hereditary cancer syndromes in an integrated health care delivery system
Muessig KR, Zepp JM, Keast E, Shuster EE, Reyes AA, Arnold B, Ingphakorn C, Gilmore MJ, Kauffman TL, Hunter JE, Knerr S, Feigelson HS, Goddard KAB. Hered Cancer Clin Pract. 2022 Feb 10;20(1):7. Epub 2022-02-10. PMID: 35144679 PMCID: PMC8832647
MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets
Qiu X, Boufaied N, Hallal T, Feit A, de Polo A, Luoma AM, Alahmadi W, Larocque J, Zadra G, Xie Y, Gu S, Tang Q, Zhang Y, Syamala S, Seo JH, Bell C, O'Connor E, Liu Y, Schaeffer EM, Jeffrey Karnes R, Weinmann S, Davicioni E, Morrissey C, Cejas P, Ellis L, Loda M, Wucherpfennig KW, Pomerantz MM, Spratt DE, Corey E, Freedman ML, Shirley Liu X, Brown M, Long HW, Labbé DP. Nat Commun. 2022 May 13;13(1):2559. Epub 2022-05-13. PMID: 35562350 PMCID: PMC9106722
Barriers to family history knowledge and family communication among LGBTQ+ individuals in the context of hereditary cancer risk assessment
Rolf BA, Schneider JL, Amendola LM, Davis JV, Mittendorf KF, Schmidt MA, Jarvik GP, Wilfond BS, Goddard KAB, Ezzell Hunter J. J Genet Couns. 2022 02;31(1):230-241. Epub 2021-07-23. PMID: 34302314 PMCID: PMC8783924
Incidence of malignancies among patients with chronic hepatitis B in US health care organizations, 2006-2018
Spradling PR, Xing J, Zhong Y, Rupp LB, Moorman AC, Lu M, Teshale EH, Schmidt MA, Daida YG, Boscarino JA, Gordon SC. J Infect Dis. 2022 Sep 13;226(5):896-900. PMID: 35039863